Sage Therapeutics' rare disease drug meets main goal in mid-stage study-March 2024-www.financetom.com

Sage Therapeutics' rare disease drug meets main goal in mid-stage study

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Sage Therapeutics' rare disease drug meets main goal in mid-stage study

Jun 11, 2024 4:12 AM

June 11 (Reuters) - Sage Therapeutics ( SAGE ) said on

Tuesday its experimental drug met the main goal of a mid-stage

study in patients with a type of rare disease known as

Huntington's disease.

Previous page： BRIEF-HomesToLife Files For U.S. IPO - SEC Filing Next page： Four tips to make the most of hybrid work

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

BRIEF-HomesToLife Files For U.S. IPO - SEC Filing

Aug 23, 2024

Aug 22 (Reuters) - * HOMESTOLIFE LTD FILES FOR U.S. IPO-SEC FILING * HOMESTOLIFE LTD - HAVE APPLIED TO LIST SHARES ON NASDAQ CAPITAL MARKET UNDER SYMBOL HTLM. * HOMESTOLIFE LTD: EXPECT IPO PRICE OF SHARES TO BE IN THE RANGE OF $4 TO $6 PER SHARE * HOMESTOLIFE LTD SAYS US TIGER SECURITIES INC. IS UNDERWRITER TO IPO *...

Four tips to make the most of hybrid work

Aug 23, 2024

NEW YORK (Reuters) - If you ever question the value of hybrid work, just have a chat with L Parker Barnum. The managing director of creative agency Mythology splits his week: three days from his home in New Jersey with two days at the firm's office in Manhattan. His verdict: The arrangement makes him more productive, not less. Avoiding the...

Intact Financial Says Q3 Catastrophe Losses "Well Above Expectations"

Aug 23, 2024

07:09 AM EDT, 08/22/2024 (MT Newswires) -- Intact Financial ( IFCZF ) overnight Wednesday said catastrophe losses from severe weather events in Canada for July and August are well above expectations for a third quarter. It said total catastrophe losses for the quarter so far are $1.1 billion on a pre-tax basis and net of reinsurance. Intact added it will...

Viking Holdings Q2 Net Income Declines, Revenue Rises; Shares Down Pre-Bell

Aug 23, 2024

07:36 AM EDT, 08/22/2024 (MT Newswires) -- Viking Holdings ( VIK ) reported Q2 net income Thursday of $0.37 per diluted share, down from $0.46 a year earlier. Analysts polled by Capital IQ expected $0.64. Revenue for the quarter ended June 30 was $1.59 billion, up from $1.45 billion a year earlier. Analysts surveyed by Capital IQ expected $1.60 billion....